CMS Seeking Comment on CLIA Rule Allowing Remote Access to Digital Laboratory Data
The Centers for Medicare & Medicaid Services is seeking comment on a proposed rule to amend regulations from the Clinical Laboratory Improvement...
1 min read
On Oct. 30, the American Hospital Association and other organizations, including the College of American Pathologists, sent a letter to U.S. House and Senate leadership urging them to pass the Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act (S.2761/H.R. 5269).
The legislation would modernize the Clinical Laboratory Fee Schedule (CLFS) with current and comprehensive commercial market data, reduce administrative data collection and reporting burdens for clinical laboratories and the Centers for Medicare & Medicaid Services, and promote diagnostic innovation through Medicare payment stability. The organizations also note that passage of the RESULTS Act would prevent pending payment cuts of up to 15 percent for about 800 clinical laboratory services, set to begin on Jan. 1, 2026.
“The CLFS represents less than 1 percent of total Medicare spending, while clinical laboratory services inform 70 percent of clinical decision-making,” the organizations wrote. “Timely access to innovative clinical laboratory tests is critical to the prevention, early detection, therapy selection, and effective management of chronic and life-threatening diseases.”
Both versions of the bill were introduced on Sept. 10 and have been referred to relevant committees for further consideration.
Source:
Bill to Reform No Surprises Act Arbitration Process Introduced in House
Rep. Frank Pallone (D-N.J.), ranking member of the House Energy & Commerce Committee, introduced legislation to fix the No Surprises Act arbitration...
UHC Drops Lp(a) from Its Non-Coverage List
UnitedHealthcare has released an updated version of its Cardiovascular Disease Risk Tests medical policy for Commercial and Individual Exchange...